Lymphangitis secondary prevention: Difference between revisions
m Changes made per Mahshid's request |
|||
| Line 18: | Line 18: | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 17:58, 18 September 2017
|
Lymphangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphangitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Lymphangitis secondary prevention |
|
Risk calculators and risk factors for Lymphangitis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]Vishal Devarkonda, M.B.B.S[3]
Overview
Lymphangitis being a manifestation of wide concurrently occurring spectrum of manifestations or pathologies. There is no established method of prevention of lymphangitis. Lymphangitis caused by recurrent skin infections due to group A beta-hemolytic streptococci can be prevented by prophylactic administration of antibiotics can reduce the risk of these skin infections complicating into lymphangitis.
Primary prevention
- There is no established primary prevention measure for lymphangitis
- Lymphangitis caused by recurrent skin infections due to group A beta-hemolytic streptococci can be prevented by prophylactic administration of antibiotics can reduce the risk of these skin infections complicating into lymphangitis.[1]
References
- ↑ Moran GJ, Abrahamian FM, Lovecchio F, Talan DA (2013). "Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines". J Emerg Med. 44 (6): e397–412. doi:10.1016/j.jemermed.2012.11.050. PMID 23466022.